In a landmark study, Agapova et al. examined the role of ActRIIA signaling in CKD-related vascular disease, using a well-established high-fat-fed, diabetic, low-density lipoprotein receptor knockout (ldlr-/-) mouse model of CKD. This evidence concerns the gene ACVR2A and chronic kidney disease.